Clinical Trial Update: CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr [Phase 2]

View source ↗

Summary

A ClinicalTrials.gov update describes the CASCADE study, a Phase 2 trial evaluating cannabidiol in children with autism spectrum disorder. The trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING